Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra

NCT05377281 is registered in ClinicalTrials.gov with Craig van Horne, MD, PhD as lead sponsor.

NCT NCT05377281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra
Lead sponsor
Craig van Horne, MD, PhD
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 7, 2022
Completion date
June 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease